Infiniwell BPC-157 Ingredients
A line-by-line look at what's inside Infiniwell BPC-157 Rapid Pro, including active components and excipients.
The formulation is deliberately minimal — a single active without an adjunctive blend. Clinically this is preferable: the dose is explicit rather than concealed within a proprietary stack of glutamine and zinc carnosine. The quantity below reflects the current capsule and should be confirmed against the Supplement Facts or label panel on the bottle.
Active Ingredients
The single active and the pharmacokinetic caveat that governs interpretation:
- Synthetic BPC-157, 500 mcg per capsule — a 15-residue pentadecapeptide derived from a gastric-juice protein sequence; the sole active
- Vegetarian capsule shell — no adjunctive fillers layered onto the active
- No proprietary blend or co-formulated botanicals — the peptide is delivered in isolation, so any glutamine or zinc-carnosine support would be a separate product
- Route caveat: this is the ORAL formulation, whereas the preclinical data are predominantly parenteral — the most defensible expectation is local enteral activity plus uncertain systemic exposure, with musculoskeletal claims least supported
Other Ingredients (Excipients)
Because the product is a single isolated active, the inactive profile is minimal: a vegetarian capsule shell without a proprietary blend or marketing-driven fillers. The clinically relevant 'inactive' variable is thermal stability rather than excipient burden. As a peptide, BPC-157 is heat-labile and can degrade under poor storage conditions — a hot vehicle or a cabinet adjacent to a heat source — so cool storage is a genuine determinant of whether the product remains active. The current label is authoritative for exact capsule composition.
Allergens and Sensitivities
As an isolated peptide in a vegetarian capsule, the product lacks the conventional supplement allergen burden — no shellfish-derived glucosamine, no dairy, no botanical matrix to cross-react with. The appropriate 'allergen-equivalent' caution for a synthetic peptide is categorical rather than immunologic: it has not undergone the human safety evaluation expected of an approved drug, so the operative cautions are population-based (malignancy, pregnancy, immunosuppression). A patient with a known excipient sensitivity should still review the current label.
Sourcing and Quality Notes
Provenance carries unusual weight for a peptide. Because BPC-157 is not a DSHEA dietary supplement and the marketplace is unsettled, the quality gap between an authorized practitioner-channel product and an anonymous marketplace listing is substantial — identity, dose accuracy, and cold-chain integrity are all in question with the latter. Acquisition through the practitioner channel or an authorized dispensary (for instance, a Fullscript storefront) is the most reliable hedge against misidentified, underdosed, or thermally degraded product. The a practitioner-written Infiniwell BPC-157 review addresses authenticity and acquisition in clinical detail. A practitioner's evaluation of Infiniwell's sourcing standards is included in this a practitioner-written Infiniwell BPC-157 review.
How Ingredients Compare to Similar Products
Two comparisons dominate the clinical decision. First, oral versus parenteral: the evidence base is overwhelmingly parenteral, the injectable is accessed through physicians and compounding pharmacies, and the oral capsule is the lower-barrier option whose best-supported activity is enteral. For an upper-GI objective the oral route is mechanistically coherent; for a systemic musculoskeletal objective it is the weaker and less-evidenced choice. Second, isolated peptide versus 'recovery complex': delivering BPC-157 in isolation preserves dosing transparency and avoids the label-padding of proprietary stacks. It also warrants stating what the agent is not — not an approved therapeutic, not a substitute for progressive loading, and not a maintenance product; it is a bounded adjunct to an active rehabilitation plan.
← Side effects · Read the FAQ →
This site provides educational information about Infiniwell BPC-157 Rapid Pro and similar nutraceutical products. It is not medical advice. Always consult a qualified healthcare professional before starting or stopping any supplement. Infiniwell BPC-157 is a registered trademark of Infiniwell; this site is independent and not affiliated with Infiniwell.